A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Tanox Inc.

About Tanox Inc.


Tanox, Inc. discovers and develops therapeutic monoclonal antibodies to address unmet medical needs in the areas of asthma, allergy, inflammation, diseases affecting the human immune system and infectious diseases.

In 2003, an anti-IgE therapy, Xolair® (Omalizumab) for Subcutaneous Use, received approval from the U.S. Food and Drug Administration for the treatment of adults and adolescents (12 years of age and above) with moderate-to-severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids.

The Company's products are genetically engineered antibodies that target a specific molecule or antigen.





TNX -355 HIV/AIDS --Target -CD4 Cells





More About Tanox

Home Page

Key Statistics for Tanox

Basic Chart for Tanox

Analyst Opinion

Analysts Estimates


Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.